Immune gene expression and response to chemotherapy in advanced breast cancer-Reference-Cited by-同舟云学术

Immune gene expression and response to chemotherapy in advanced breast cancer

Published:2018-01-25 Issue:4 Volume:118 Page:480-488
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Foukakis Theodoros, ,Lövrot John,Matikas Alexios,Zerdes Ioannis,Lorent Julie,Tobin Nick,Suzuki Chikako,Brage Suzanne Egyházi,Carlsson Lena,Einbeigi Zakaria,Linderholm Barbro,Loman Niklas,Malmberg Martin,Fernö Mårten,Skoog Lambert,Bergh Jonas,Hatschek Thomas

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2017446.pdf

Reference36 articles.

1. Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphner TJ, Wolff AC, Wood WC, Davidson NE, Sledge GW, Sparano JA, Badve SS (2014) Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol 32 (27): 2959–2966.

2. Amadori D, Volpi A, Maltoni R, Nanni O, Amaducci L, Amadori A, Giunchi DC, Vio A, Saragoni A, Silvestrini R (1997) Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: a prospective study. Breast Cancer Res Treat 43 (1): 7–14.

3. Amir E, Clemons M, Purdie CA, Miller N, Quinlan P, Geddie W, Coleman RE, Freedman OC, Jordan LB, Thompson AM (2012) Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies. Cancer Treat Rev 38 (6): 708–714.

4. Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautes-Fridman C, Fridman WH, de Reynies A (2016) Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol 17 (1): 218.

5. Bonsang-Kitzis H, Sadacca B, Hamy-Petit AS, Moarii M, Pinheiro A, Laurent C, Reyal F (2016) Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis. Oncoimmunology 5 (1): e1061176.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relevance Analysis of TPM2 and Clinicopathological Characteristics in Breast Cancer;International Journal of General Medicine;2024-01

2. It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer;Frontiers in Immunology;2023-10-18

3. Integrative landscape analysis of prognostic model biomarkers and immunogenomics of disulfidptosis-related genes in breast cancer based on LASSO and WGCNA analyses;Journal of Cancer Research and Clinical Oncology;2023-09-22

4. Promotion of ICD via Nanotechnology;Macromolecular Bioscience;2023-05-07

5. Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial;Clinical Cancer Research;2023-04-04